NO20034413D0 - Beta-karbolinderivater og deres farmasöytiske anvendelse mot depresjon og angst - Google Patents

Beta-karbolinderivater og deres farmasöytiske anvendelse mot depresjon og angst

Info

Publication number
NO20034413D0
NO20034413D0 NO20034413A NO20034413A NO20034413D0 NO 20034413 D0 NO20034413 D0 NO 20034413D0 NO 20034413 A NO20034413 A NO 20034413A NO 20034413 A NO20034413 A NO 20034413A NO 20034413 D0 NO20034413 D0 NO 20034413D0
Authority
NO
Norway
Prior art keywords
anxiety
beta
pharmaceutical use
use against
carboline derivatives
Prior art date
Application number
NO20034413A
Other languages
English (en)
Other versions
NO20034413L (no
Inventor
Thomas J Troxler
Konstanze Hurth
Daniel Hoyer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20034413D0 publication Critical patent/NO20034413D0/no
Publication of NO20034413L publication Critical patent/NO20034413L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20034413A 2001-04-03 2003-10-02 Beta-karbolinderivater og deres farmasöytiske anvendelse mot depresjon og angst NO20034413L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0108337.7A GB0108337D0 (en) 2001-04-03 2001-04-03 Organic compounds
PCT/EP2002/003624 WO2002081471A1 (en) 2001-04-03 2002-04-02 Beta-carboline derivatives and its pharmaceutical use against depression and anxiety

Publications (2)

Publication Number Publication Date
NO20034413D0 true NO20034413D0 (no) 2003-10-02
NO20034413L NO20034413L (no) 2003-10-02

Family

ID=9912165

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034413A NO20034413L (no) 2001-04-03 2003-10-02 Beta-karbolinderivater og deres farmasöytiske anvendelse mot depresjon og angst

Country Status (27)

Country Link
US (1) US6861430B2 (no)
EP (1) EP1377578B1 (no)
JP (1) JP4405732B2 (no)
KR (1) KR100564840B1 (no)
CN (1) CN1309721C (no)
AR (1) AR035451A1 (no)
AT (1) ATE517104T1 (no)
AU (1) AU2002316828B2 (no)
BR (1) BR0208566B1 (no)
CA (1) CA2440014C (no)
CZ (1) CZ295992B6 (no)
EC (1) ECSP034754A (no)
ES (1) ES2368389T3 (no)
GB (1) GB0108337D0 (no)
HU (1) HUP0400317A3 (no)
IL (1) IL157545A0 (no)
MX (1) MXPA03009057A (no)
MY (1) MY134026A (no)
NO (1) NO20034413L (no)
NZ (1) NZ528370A (no)
PE (1) PE20021018A1 (no)
PL (1) PL210861B1 (no)
PT (1) PT1377578E (no)
RU (1) RU2003130644A (no)
SK (1) SK12222003A3 (no)
WO (1) WO2002081471A1 (no)
ZA (1) ZA200306108B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
EP1637521B1 (en) * 2003-06-23 2013-06-19 Ono Pharmaceutical Co., Ltd. Novel tricyclic heterocycle compound
AR051780A1 (es) * 2004-11-29 2007-02-07 Japan Tobacco Inc Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
JP4997976B2 (ja) 2004-12-22 2012-08-15 小野薬品工業株式会社 三環式化合物およびその用途
US7879859B2 (en) 2005-11-21 2011-02-01 Merck Sharp & Dohme Corp. Diagnosis and treatment of type 2 diabetes and other disorders
US20070149557A1 (en) * 2005-11-21 2007-06-28 Amgen Inc. CXCR3 antagonists
EP2178537A4 (en) * 2007-07-19 2011-08-17 Merck Sharp & Dohme BETA-CARBOLIN DERIVATIVES AS ANTIDIBLE COMPOUNDS
WO2009016329A1 (en) * 2007-07-31 2009-02-05 Cambridge Enterprise Limited Use of gabaa receptor antagonists to treat cognitive impairment in patients with psychiatric conditions
CN102131805A (zh) 2008-06-20 2011-07-20 百时美施贵宝公司 用作激酶抑制剂的咪唑并吡啶和咪唑并吡嗪化合物
PL2540297T3 (pl) 2008-11-19 2015-12-31 Forum Pharmaceuticals Inc Leczenie zaburzeń funkcji poznawczych(R)-7-chloro-N-(chinuklidyn-3-ylo)benzo[b]tiofeno-2-karboksyamidem i jego farmaceutyczne dopuszczalnymi solami
TW201028414A (en) * 2009-01-16 2010-08-01 Merck Sharp & Dohme Oxadiazole beta carboline derivatives as antidiabetic compounds
WO2011088025A1 (en) 2010-01-15 2011-07-21 Merck Sharp & Dohme Corp. Oxadiazole beta carboline derivatives as antidiabetic compounds
PL3029039T3 (pl) 2010-05-17 2018-04-30 Forum Pharmaceuticals Inc. Formulacje farmaceutyczne zawierające postacie krystaliczne jednowodnego chlorowodorku (R)-7-chloro-N-(chinuklidyn-3-ylo)benzo[b]tiofeno-2-karboksyamidu
AU2013259871A1 (en) 2012-05-08 2014-11-20 Forum Pharmaceuticals Inc. Methods of maintaining, treating or improving cognitive function
CN111349096B (zh) * 2020-04-14 2021-03-09 石河子大学 一种吲哚类化合物及其制备方法、应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4118741A1 (de) * 1991-06-05 1992-12-10 Schering Ag Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln
US6057340A (en) * 1998-02-03 2000-05-02 American Home Products Corporation Oxazole derivatives as serotonin-1A receptor agonists
ATE229954T1 (de) 1998-06-12 2003-01-15 Sod Conseils Rech Applic Betacarbolinverbindungen

Also Published As

Publication number Publication date
CZ295992B6 (cs) 2005-12-14
CA2440014A1 (en) 2002-10-17
HUP0400317A2 (hu) 2004-09-28
SK12222003A3 (sk) 2004-06-08
PL362571A1 (en) 2004-11-02
CN1500090A (zh) 2004-05-26
KR20040008150A (ko) 2004-01-28
AU2002316828B2 (en) 2006-05-11
EP1377578A1 (en) 2004-01-07
JP4405732B2 (ja) 2010-01-27
HUP0400317A3 (en) 2007-10-29
BR0208566A (pt) 2004-03-30
PT1377578E (pt) 2011-09-23
ATE517104T1 (de) 2011-08-15
PE20021018A1 (es) 2003-01-13
GB0108337D0 (en) 2001-05-23
AR035451A1 (es) 2004-05-26
CZ20032655A3 (cs) 2003-12-17
IL157545A0 (en) 2004-03-28
ES2368389T3 (es) 2011-11-16
CN1309721C (zh) 2007-04-11
ECSP034754A (es) 2003-10-28
US6861430B2 (en) 2005-03-01
EP1377578B1 (en) 2011-07-20
US20040132735A1 (en) 2004-07-08
NZ528370A (en) 2005-10-28
ZA200306108B (en) 2004-07-05
KR100564840B1 (ko) 2006-03-28
JP2004525178A (ja) 2004-08-19
PL210861B1 (pl) 2012-03-30
CA2440014C (en) 2010-11-23
BR0208566B1 (pt) 2013-12-24
MXPA03009057A (es) 2004-02-12
MY134026A (en) 2007-11-30
WO2002081471A1 (en) 2002-10-17
NO20034413L (no) 2003-10-02
RU2003130644A (ru) 2005-04-10

Similar Documents

Publication Publication Date Title
NO2023030I1 (no) Apixaban and pharmaceutical acceptable salts thereof
CY2016022I2 (el) Παραγωγο 2-οξο-1-πυρρολιδινης και οι φαρμακευτικες του χρησεις
DK1578755T3 (da) Phosphonooxyguinalinderivater og deres farmaceutiske anvendelse
DK1354888T3 (da) Glukopyranosyloxypyrazolderivater og anvendelse deraf i medikamenter
NO20025357L (no) Antranylamider og deres anvendelse som legemidler
DK1673349T3 (da) Benzimidazolderivater: fremstilling og farmaceutiske anvendelser
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
DK1373191T3 (da) Acylerede indanylaminer og deres anvendelse som lægemidler
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
EP1367060A4 (en) GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE
EP1364957A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND THEIR MEDICAL USE
EP1364958A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF
IS2485B (is) Fenýlsúlfónýl-1,3-díhýdró-2H-indól-2-ón afleiður,framleiðsla þeirra og notkun í meðferðarskyni
DK1453517T3 (da) Farmaceutiske formuleringer med platinderivat
DE60319951D1 (de) Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate
NO20034413D0 (no) Beta-karbolinderivater og deres farmasöytiske anvendelse mot depresjon og angst
NO20026122L (no) Terapeutisk preparat mot angstneurose eller depresjon og piperazinderivater
EE200200607A (et) 2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena
NO20025158D0 (no) Lipidpreparat og anvendelse derav
DK1513835T3 (da) Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
DK1590321T3 (da) Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
DK1387838T3 (da) Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
IS6723A (is) 10-arýl-11H-bensó[b]flúorenafleiður og hliðstæðurtil lyfjanotkunar
DK1556382T3 (da) 3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application